
A major challenge facing the world’s health care systems is paying for a new breed of expensive breakthrough drugs. One way to address the issue is to approach it the same way as other industries where suppliers encourage investment through approaches such as equipment leases or supplier-financed credit.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/o8UEFOI_eZo/150311081925.htm